Literature DB >> 16807967

Ruthenation of duplex and single-stranded d(CGGCCG) by organometallic anticancer complexes.

Hong-Ke Liu1, Fuyi Wang, John A Parkinson, Juraj Bella, Peter J Sadler.   

Abstract

We have studied the interaction of the organometallic anticancer ruthenium(II) complexes [(eta(6)-p-cymene)Ru(en)Cl][PF(6)] (1) and [(eta(6)-biphenyl)Ru(en)Cl][PF(6)] (2) (en=ethylenediamine) with the single-stranded (ss) DNA hexamer d(CGGCCG) (I) and the duplex d(CGGCCG)(2) (II) by HPLC, ESI-MS, and one- and two-dimensional (1)H and (15)N NMR spectroscopy. For ss-DNA, all three G's are readily ruthenated with [(eta(6)-arene)Ru(en)](2+), but for duplex DNA there is preferential ruthenation of G3 and G6, and no binding to G2 was detected. For monoruthenated duplexes, N7 ruthenation of G is accompanied by strong hydrogen bonding between G-O6 and en-NH for the p-cymene adducts. Intercalation of the non-coordinated phenyl ring between G3 and C4 or G6 and C5 was detected in the biphenyl adducts of mono- and diruthenated duplexes, together with weakening of the G-O6NH-en hydrogen bonding. The arene ligand plays a major role in distorting the duplex either through steric interactions (p-cymene) or through intercalation (biphenyl).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16807967     DOI: 10.1002/chem.200600110

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  7 in total

1.  Reactivity of hexanuclear ruthenium metallaprisms towards nucleotides and a DNA decamer.

Authors:  Lydia E H Paul; Bruno Therrien; Julien Furrer
Journal:  J Biol Inorg Chem       Date:  2014-11-08       Impact factor: 3.358

Review 2.  Unusual DNA binding modes for metal anticancer complexes.

Authors:  Ana M Pizarro; Peter J Sadler
Journal:  Biochimie       Date:  2009-04-01       Impact factor: 4.079

3.  A comparative DFT study on aquation and nucleobase binding of ruthenium (II) and osmium (II) arene complexes.

Authors:  Hanlu Wang; Xingye Zeng; Rujin Zhou; Cunyuan Zhao
Journal:  J Mol Model       Date:  2013-09-15       Impact factor: 1.810

4.  Controlling Platinum, Ruthenium and Osmium Reactivity for Anticancer Drug Design.

Authors:  Pieter C A Bruijnincx; Peter J Sadler
Journal:  Adv Inorg Chem       Date:  2009-07-07       Impact factor: 3.282

Review 5.  Organometallic anticancer compounds.

Authors:  Gilles Gasser; Ingo Ott; Nils Metzler-Nolte
Journal:  J Med Chem       Date:  2010-11-15       Impact factor: 7.446

6.  CORM-3 induces DNA damage through Ru(II) binding to DNA.

Authors:  Rhiannon F Lyon; Hannah M Southam; Clare R Trevitt; Chunyan Liao; Sherif F El-Khamisy; Robert K Poole; Mike P Williamson
Journal:  Biochem J       Date:  2022-07-15       Impact factor: 3.766

7.  Binding of Organometallic Ruthenium Anticancer Complexes to DNA: Thermodynamic Base and Sequence Selectivity.

Authors:  Suyan Liu; Aihua Liang; Kui Wu; Wenjuan Zeng; Qun Luo; Fuyi Wang
Journal:  Int J Mol Sci       Date:  2018-07-23       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.